Brief: Paion announces clinical development progress with remimazolam by its partner Yichang Humanwell

PAION AG

06/09/2016 13:00

Sept 6 (Reuters) - Paion AG  PA8G.DE : 
    * Announces clinical development progress with remimazolam 
by its partner Yichang Humanwell in China 
    * First phase I study started in october 2015 has completed 
recruitment 
    * A phase II study in procedural sedation is in preparation 
    * Yichang Humanwell has started a new phase I study with 
continuous infusion 
 
Source text for Eikon:  ID:nEQ8CzHVKa  
Further company coverage:  PA8G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))